IBE.MC (IBE.MC)

$132.5B
Market Cap
23.3
P/E Ratio
0.65
Beta
3.46%
Dividend Yield
Piotroski 7/9Altman Z 1.6 DistressROIC−WACC -1.6%

Quantitative Summary

Deterministic

Strong operational fundamentals (Piotroski 7/9) with Altman Z of 1.6.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency for IBE.MC presents a structural challenge, with an ROIC of 6.1% falling below the cost of equity at 7.7%, resulting in a negative spread that erodes intrinsic value over time despite high profitability metrics. The DuPont decomposition reveals a tension between robust margin expansion—evidenced by a 54.6% gross and 14.3% net margin—and sluggish operational scaling, as revenue growth remains stagnant at just 2.5%. While the Piotroski F-Score of 7/9 suggests strong balance sheet fundamentals and earnings quality, an Altman Z-Score of 1.6 flags a heightened probability of financial distress relative to historical norms, creating a dichotomy between current profitability and long-term solvency risk.

Valuation metrics indicate a significant divergence from fundamental value, with the stock trading at 23.3x forward earnings while the DCF model assigns a fair value of $3, implying substantial downside if growth assumptions hold steady. The market appears to be pricing in aggressive future expansion that is not currently reflected in the modest year-over-year revenue trajectory or the negative ROIC-WACC spread. This disconnect suggests investors are anticipating a multiple contraction unless operational leverage improves sufficiently to bridge the gap between current returns and capital costs, potentially rendering the premium valuation unsustainable given the underlying cash flow generation constraints.

The risk profile is further complicated by conflicting signals regarding stability versus distress; while the high F-Score points to favorable accounting trends, the low Z-Score introduces non-trivial bankruptcy risk that could trigger a sharp re-rating of equity value. Without evidence of accelerated growth or improved capital efficiency to offset the negative spread, the current setup exposes shareholders to potential value destruction if management fails to address the fundamental misalignment between return on invested capital and the hurdle rate required for shareholder wealth creation.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%7.7%9.7%
2%$5$2$0
3%$8$3$0
4%$13$5$1

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=7.7%, terminal growth 3%. Fair value $3 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
1.6
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

54.6%
Gross Margin
14.3%
Net Margin
6.1%
ROIC
7.7%
WACC
ROIC − WACC Spread: -1.6%— Negative spread.
+2.5%
Revenue Growth (YoY)
+12.0%
Earnings Growth (YoY)
3.3B
Free Cash Flow
38%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

1.53x
Debt / Equity
0.87x
Current Ratio
4.7x
Interest Coverage
2.3x
Net Debt / EBITDA
1.94%
FCF Yield
16.8B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.27
Act: $0.30
+11.9%
Q3
✓ Beat
Est: $0.23
Act: $0.23
+1.3%
Q2
✓ Beat
Est: $0.22
Act: $0.24
+8.6%
Q1
✓ Beat
Est: $0.14
Act: $0.15
+8.1%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

18.4
Forward P/E
PEG Ratio
2.58
Price/Book
11M
Avg Volume
$20.38
52W High
$14.04
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in IBE.MC to visualize passive redemption contagion across ETFs and collateral stocks.

IBE.MC Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
IBE.MCEpicenterEZUETFASML.ASLow RiskSIE.DEMed RiskTTE.PAHigh RiskSAN.MCHigh RiskSAP.DELow Risk
IBE.MC Price Drop (%)0

If IBE.MC (IBE.MC) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding NV (ASML.AS) as the most exposed collateral stock, sharing 1 ETFs with IBE.MC. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

IBE.MC Ownership Dynamics

Ticker
IBE.MC

ETFs with Highest IBE.MC Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

IBE.MC Capital Efficiency

How efficiently does IBE.MC convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$3.3B
EBITDA
$16.8B
FCF Conversion
20%
Reinvestment Rate
80%
20% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
6.1%
ROIC − WACC Spread
-1.6%

IBE.MC converts 20% of its EBITDA into free cash flow, a low conversion rate suggesting heavy reinvestment. This may indicate a growth phase (building capacity) or structural capital intensity. The 80% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-1.6%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare IBE.MC to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.